INTRODUCTION
There occur in our environment today a large number of compounds which are normally regarded as foreign to the body. Many ofthese get into the body in various ways and therefore it is important to know how they affect our health and how the body deals with them. These chemieals may appear in the body because they have been deliberately put there as in the case of drugs, deliberate food additives and contraceptive pills, or because they have entered the body accidentally as contaminants of food, drink and air. These contaminants may be pesticide residues, industrial chemieals in factories, products froni the preparation and packaging of food, and foreign substances which occur naturally in food but have no nutrient function. The animal body has therefore to deal constantly with small quantities of thousands of compounds of very diverse chemical structures (see Table 1 ). Many ofthese chemieals are toxic and man is therefore Iiving in a toxic environment. In view of the increasing use of drugs, pesdeides and food additives, there is Iittle doubt that we are existing in an increasingly toxic environment. Even before the modern era of drugs, food additives and pesticides, the human body had to cope with a Iarge number of toxic substances which occur naturally in food 1 • The fact that our environment is becoming increasingly toxic raises the problern of what is the Iimit of intake of environmental toxic agents that the body can withstand. Does adaption occur? Can we keep on adding new chemieals to those already existing in the environment or must we now take account of what already occurs and become cautious and selective regarding the future use of environmental chemicals. There is evidence that man can adapt to some extent to toxic chemicals, but this is no reason for being complacent about the increasing Ievels of ambient toxicity. The answers to the above questions lie in our knowledge of the extent to which the body can detoxicate and eliminate foreign chemicals. The diversity of chemical structures which the body has to deal with is illustrated in Table 2 which gives a selection of the structures of some of the commoner chemieals which may get into the organism in various ways. 
THE FATE OF FOREIGN COMPOUNDS IN MAN AND ANIMALS
The animal body, is in fact, amazingly versatile for it can metabolize almost any known chemical structure except some highly polar compounds and some chemically unreactive substances. An example of a substance which is not metabolized at all, and which was examined in my laboratory recently2, is 5,5' -methylenedisalicylic acid ( 4,4' -dihydroxydiphenylmethane-3,3'-dicarboxylic acid). The bacitracin salt of this substance is used as an animal feed supplement for poultry, swine and mink. 5,5' -Methylenedisalicylic acid (see below) is excreted entirely unchanged in the rhesus monkey, dog, rabbit, guinea pig, hamster, mouse, rat and hen.
GENERAL ASPECTS OF DRUG METABOL18M
Much of the effort in the study of the metabolism of foreign compounds has, in the past, been devoted to drugs, and consequently this study is frequently referred to as "drug metabolism". However, the principles of drug metabolism apply equally weil to any foreign compound, be it a drug, a pesticide, a food additive or an industrial chemical.
A foreign compound which gains access to the animal body encounters a large number of enzymes some ofwhich are able to react with it and submit it to a variety of reactions which can be classified as oxidations, reductions, hydrolyses and syntheses. As a result of these processes the compound is converted into metabolites which are eliminated usually in the urine and faeces, although in some cases there may be elimination through other channels such as the expired air, skin, milk and saliva. Urinary and faecal excretion may also be preceeded by biliary excretion and entero-hepatic circulation and these, if they occur, have important consequences.
In general, the metabolism of a foreign compound occurs in two phases. In the first phase the compound undergoes reactions (asynthetic) which may be classified as oxidations, reductions or hydrolyses andin the second phase, the products of the first phase undergo reactions which are synthetic in nature, thus:
Oxidation, Conjugation Foreign In each phase the foreign compound, which is usually Iipid soluble, is made more polar, for phase I products are more polar than the initial compound and phase II products are highly polar and are frequently strongly acidic substances. The fact that the conjugation or phase II products are highly polar may be one of the reasons why highly polar foreign compounds are not metabolized or at least are only metabolized to a slight extent. The metabolism of a foreign compound thus appears to be a process aimed at R. T. WILUAMS increasing its polarity rather than reducing its toxicity. As a consequence of this two-phase metahoHe process, the products which may he excreted as the result of a foreign compound entering the hody, are therefore, (a) the unchanged compound, (h) products of oxidation, reduction or hydrolysis, and (c) conjugation products. The proportion in which these products are excreted depends on a variety of factors, the major ones heing the chemical nature of the foreign compound and the species of animal examined. These factors are considered later.
THE ENZYMES OF PHASE I REACTIONS
Bach ofthe phases ofdrug metahoHsm is controlled hy enzymes, and those of the asynthetic first phase can he hroadly divided into two groups which can he called parametahoHe and xenometahoHc enzymes4.
The metahoHsm of some foreign compounds is mediated hy enzymes of normal metahoHe routes and therefore such enzymes have hoth natural and foreign suhstrates. These are the parametahoHe enzymes, examples of which are given in Table 3 . The metaholism of a foreign compound hy enzymes of this type can sometimes result in toxicity, a classical example of this heing Table 3 . Some foreign compounds metabolized by "normal" enzymes fluoroacetic acid. The enzymes which metaholize acetic acid via acetylcoenzyme A to citric acid appear also to he ahle to metaboHze fluoroacetate, and it is now accepted that the toxicity of fluoroacetate is due to its conversion by these enzymes to fluorocitrate. The latter inhibits the enzyme, aconitase, and therehy the tricarboxylic acid is jammed so that the transmission ofmetaholic energy to the cell is prevented5.
THE FATE OF FOREIGN COMPOUNDS IN MAN AND ANIMALS
The metabolism of many drugs is carried out by enzymes which occur predominantly in the endoplasmic reticulum of the liver cells. When the liver is homogenized, the endoplasmic reticulum is disrupted to form small lipoid particles called microsomes, which can be separated by centrifugation. The main drug metabolizing ability of the liver is associated with these particles, which are able to carry out a variety of oxidations, reductiom and hydrolyses (see Table 4 ). These microsomal or "drug-metabolizing" enzymes& appear to metabolize only foreign compounds and can therefore be referred to as xenometabolic enzymes. However, the question ofwhether 3 have shown that the liver microsomal enzymes which hydroxylate steroids have properties which are very similar to the xenometabolic enzymes which appear to metabolize only foreign compounds. It is possible that the property required by a compound to be a substrate of the microoomal drug metabolizing enzymes is not that it is foreign to the body, but simply that it is lipid soluble, so that it can penetrate the microsome to the sites of enzyme activity.
PHARMACOLOGICAL AND TOXICOLOGICAL CONSEQ.UENCES OF PHASE I REACTIONS7,s
When drugs and foreign compounds enter the body it is important that they should, in due course, be removed from the body. In the case of a drug it is also important that its activity should be terminated after an appropriate time, for termination of drug action in most cases is as important as the action itself. Many drugs exist in a non-polar form at physiological pH values and in this form, when they reach the kidney, they tend to be reabsorbed into the circulation by the kidney tubule. The metabolism of drugs is therefore important in the termination of their activity and in their excretion, for during this process they are converted into polar compounds which are more readily excreted by the kidney. Without these metabolic changes, some drugs would have an unreasonably long duration of action and consequendy an increased toxicity and what is said about drugs also applies to any other foreign compound which may enter the body.
It is therefore of importance to examine the nature of the metabolites produced during the processes of oxidation, reduction and hydrolysis. Although these proces<>es may convert a compound into a more polar product, they do not necessarily convert it into a product which is less active biologically. As a result of these asynthetic reactions a compound could be made (a) less active, or (b) more active, or (c) it could be converted into a compound of similar activity or different activity. These reactions are therefore not necessarily detoxication or inactivation processes. However, it can be said that in general, phase I reactions tend to produce less active or inactive products.
The production of biologically active substances by phase I reactions is of considerable interest and application, because they may lead to new drugs or new insecticides, etc. Many examples of this type of metabolic reaction are now known. Furthermore, this type ofreaction explains why some substances are biologically inactive in vitro, but active in vivo. Thus phenacetin, prontosil, and chioral hydrate are pharmacologically active because they are converted in the body into active metabolites. Phenacetin is oxidatively de-ethylated in vivo to p-acetamidophenol (panadol; paracetamol), whereas chioral hydrate and prontosil are reduced to their active metabolites which are trichloroethanol and sulphanilamide, respectively. Similarly, the pesticides schradan and parathion, owe their activity to being converted in vivo to toxic metabolites. However, many drugs and other foreign compounds have their activity reduced by phase I reactions, common examples being the barbiturate drugs whose duration of action depends upon the rate of the inactivating metabolic reaction. A few examples of foreign compounds undergoing these reactions are shown in Table 5 . 
PHASE II REACTIONS OR CONJUGATIONS9
As already pointed out the first phase of drug metabolism does not necessarily lead to detoxication, but in the second phase the large majority of foreign compounds are converted into water-soluble and non-toxic substances which are readily excreted in the urine. This synthetic phase Ieads to the formation of strong organic acids such as glucuronides, ethereal sulphates, mercapturic acids and amino acid conjugates such as hippuric acids. A list of these conjugation processes is given in Table 6 . 
THE FATE OF FOREIGN COMPOUNDS IN MAN AND ANIMALS

FACTORS AFFECTING THE METABOL18M OF FOREIGN COMPOUNDS ""
It is now clear that various phases of drug metabolism are controlled by enzymes, and any factor which affects these enzymes affects the metabolism ofthe compound and consequently its toxicity and pharmacological activity.
There are many factors which affect the metabolism of a drug and these can be listedas follows: species, sex, strain (genetic factors), age, diet, stress, temperature, chronic administration, disease, and the presence of other chemicals. Recently it has become clear also that biliary excretion may be important, because this introduces the question ofthe metabolism offoreign compounds by gut bacteria. It is possible that gut bacteria play a greater role in drug metabolism than has been hitherto realised.
It is not possible within the time allotted to this lecture to deal with all the factors which may modify the metabolism of a foreign compound and consequently its toxicity and pharmacological activity. Therefore, I shall confine my remarks to three of these, namely the species factor which is also related to the factor of biliary excretion, and the problern of the effect one chemical has upon the metabolism of another.
SPECmS DIFFERENCES IN DRUG METABOLISM4
The safety of drugs and other chemieals for use in man is determined by tests on laboratory animals, but the activity and toxicity of these chemieals are not always the same in animals as they are in man. One reason for these diffetences is that the metabolism Q[ a compound in laboratory animals often differs from that in man, both qualitatively and quantitatively. Species differences in drug metabolism depend mainly upon differences in the enzymes which control phase I and phase II reactions. These differences in enzyme activity can be due to several causes such as the following: (a) the absolute amount ofan enzyme mayvarywith species; (b) the amount ofa natural inhibitor ofan enzyme may vary; (c) the amount ofan enzyme reversing a reaction may vary; and (d) there may be a species variation in the enzymic control ofreactions competing for the same substrate. Examples of all these possibilities are known, but it is not possible to deal with all of them here.
A striking example of a metahoHe reaction which seems to be confined to a few related species of animals is the conversion of l-quinic acid to hippuric acid in vivo. Quinic acid occurs in tea, coffee, fruits and vegetables as a component of chlorogenic acid, and in man it is converted by aromatization to benzoic acid which is excreted as hippuric acid (see below). Studies in my laboratory have shown that this reaction is confined to man and the Old 
Hippuric acid
World Monkeys, and it does not occur to any large extent in New World Monkeys and common laboratory animals (see Table 7 ). This reaction suggests a close correlation between man and the Old World Monkeys. The reaction itself is a remarkable one and its mechanism is unknown. However, we have obtained results very recently to show that the reaction may be carried out by gut bacteria, for if the rhesus monkey is given 2 g of neomycin daily by mouth for six days, the aromatization of quinic acid is abolished in this animal. Aromatization does not occur if quinic acid is injected intraperitoneally. Another interesting example is amphetamine. In the rat, this compound is mainly hydroxylated to p-hydroxyamphetamine, whereas in the rabbit it is mainly deaminated and converted to hippuric acid. The extent ofhydroxylation of amphetamine in various species is shown in Table 8 which suggests that the hydroxylation of amphetamine is haphazard as far as species is concerned, although the monkeys are like man in this respect.
As far as conjugation mechanisms are concerned, we again find species variation. In fact, some species are defective in some of the conjugations which occur in man. Thus the cat is defective in glucuronide synthesis, the dog cannot acetylate aromatic amines, the pig is said to be defective in sulphate conjugation and the hen does not conjugate aromatic acids with glycine. Man hirnself does not readily form mercapturic acids.
Glucuronide formation is one of the most widespread and versatile of the conjugation mechanisms, for glucuronides can be formed with compounds containing OH, COOH, NH2, NH, SH and CSSH groupslo. It occurs widely in species from amphibians to man, but is defective in cats and is replaced in insects by glucoside conjugation.
Recently a remarkable species difference ·in glucuronide formation was discovered in my laboratory which again shows that monkeys are similar to man in many of the reactions of foreign compounds. This was in connection with the formation of N-glucuronides. lt has been shown that there are four types of N-glucuronide formed in vivo. These are, The drug sulphadimethoxine (madribon) forms a sulphonimide glucuronide as a major metabolite in primates including man, the monkeys, and the lemurs, but not in common laboratory animalsll (see Table 9 ). Another reaction which indicates a close relationship between man and sub-human primates is the conjugation of arylacetic acids (e.g. phenylacetic and indolylacetic acids) with glutamine4, 9, This conjugation occurs in man and Old World Monkeys (reaction a below) but not in the Iernurs and common laboratory animals which form glycine conjugates with this type of acid (reaction b). In hens arylacetic acids are converted into omithine conjugates (reaction c).
ArCH 2 C0 2 H X ArCH2CO .::'mCH2COzH ~ ArCH 2 CO .NHCH(C02H) (CH2)J~HCOCH2Ar
BILIARY EXCRETION AND DRUG METABOLISMI2,13
The bile can be an important channel of elimination of some foreign compounds, and such elimination can have important consequences. As a result of biliary excretion a compound despite being readily absorbed from the intestine could be excreted largely in the faeces. It could also undergo entero-hepatic circulation and be extensively degraded by gut bacteria. Recent work in my laboratory has shown that the biliary excretion of a compound depends upon molecular weight and upon species. The ability to form conjugates, particularly glucuronic acid conjugates, may also be important in biliary excretion.
Compounds with small molecular weights, i.e. up to about 200--250, are not extensively excreted in the bile in any speciesl4, but as the molecular weight increases above this value biliary excretion tends to increase. This molecular weight effect is particularly marked in the rat, dog and hen, but less so in the cat and sheep. In the rabbit and guinea pig the molecular weight effect is present but it is not very marked. Thus a compound of low molecular weight such as benzoic acid (mol. wt. 122) is excreted in the bile only to the extent of 1-2 per cent mainly as its conjugates in all the species examined, including the dog, cat, rat, hen, guinea pig and rabbit. However, the large molecule succinylsulphathiazole (mol. wt. 355) has a biliary excretion of20-30 per cent in the rat, dog and hen, 7-12 per cent in the cat and sheep and only 1 per cent of the dose in the rabbit and guinea pig. The rhesus monkey is also a poor biliary excretor and behaves like the rabbit and guinea pig in this respectl5,
The reasons for the differences in the extent of biliary excretion in these species are not yet ·clear, but it appears that compounds which are readily excreted in the bile in the rat also penetrate easily into the liver, whereas in the rabbit penetration into the liver does not occur readilyi6.
THE INFLUENCE OF ONE COMPOUN D ON THE METABOLISM OF ANOTHER
It is now known that one foreign compound can influence the metabolism of another. Since a large number of foreign compounds occur in the environment, it is important to know which ones interact, especially those where interaction causes increased toxicity or, in the case of drugs, an altered therapeutic efficiency. One compound can affect the metabolism of another in two ways, namely by inhibiting its metabolism or by accelerating its metabolismB. If this occurs then four situations can arise as illustrated in Table 10 . Table 10 . The effect of one compound upon the metabolism and toxicity of another In Table 10 , A is the parent compound, C is its metabolite and B is a second foreign compound or drug. If B inhibits the enzyme which converts A to C, then the biological activity of A is diminished if C is an active or toxic metabolite [see (a) Table 10 ], but if Ais an active or toxic compound and its metabolite C is inactive, then B will increase the activity or toxicity of A [see (b) in Table 10 ]. The reverse situations occur [see (c) and (d) in Table 10 ] if B activates the enzyme which converts A to C.
Many examples of these situations have been found to occur in practice especially where mixtures of drugs or of pesticides have been usedl7. It follows also from the situations listed in Table 10 that pesticides and food additives could affect the metabolism of drugs and consequently their therapeutic activity. The reverse should also be true that drugs could affect the toxicity of other chemieals in the environment. Several examples of drugs affecting each other's activity through the activation of drug metabolizing enzymes are now known, such as the lowering fj the anticoagulant activity of warfarin and dicoumarol by phenobarbitone. The chlorinated insecticides chlordane, dieldrin and DDT are known to stimulate drugmetabolizing enzymes and therefore can affect the activity of drugs. The reported resistance of rats to warfarin in some areas may be due to their exposure to insecticides in the countryside. The toxicity of certain foodstuffs, such as cheese, to patients receiving antidepressant drugs, such as tranylcypromine, is due to the drug inhibiting the enzyme which detoxicates pressor amines occurring naturally in food.
The study of the fate of foreign compounds in man and anirnals plays an increasingly important role in the assessment of the safety of drugs and other chemieals in the environment. Furthermore, such a study helps to increase our understanding of the mode of toxic action of such substances and should Iead the way to producing more effective and less toxic rnaterials for human use.
